News from takeda pharmaceutical company limited A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 16, 2015, 23:11 ET
Researchers at Takeda and CiRA at Kyoto University, Japan, will collaborate on developing game-changing therapeutics by applying iPS cell and related technologies to pharmaceutical R&D activities, such as drug discovery, cell therapy and drug safety. CiRA Director Shinya Yamanaka, a Nobel laureate for his work on iPS cells, will direct the program, while Takeda provides long-term funding, recommendations on research management, and facilities at Shonan Research Center.

CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research

 Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today that...

Apr 14, 2015, 19:00 ET

FDA Advisory Committee Reviews Takeda's Alogliptin EXAMINE Cardiovascular Safety Outcomes Trial

Takeda Pharmaceuticals U.S.A. Inc. and Takeda Pharmaceutical Company Limited, ("Takeda") today announced that members of the Endocrinologic and...

Apr 13, 2015, 08:40 ET

Takeda Announces Appointment of New President of U.S. Business Unit

 Takeda Pharmaceutical Company Limited ("Takeda"), and Takeda's wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. ("TPUSA")...

Mar 09, 2015, 20:20 ET

Takeda Announces Publication in The Lancet of a Post Hoc Analysis of Data from the EXAMINE Cardiovascular Safety Outcomes Trial

Takeda Pharmaceutical Company Limited (Takeda) announced that a post hoc analysis of data from the global EXAMINE (EXamination of CArdiovascular...

Mar 09, 2015, 13:15 ET

Takeda Hosts Investor Briefing on its Global Leadership in Gastroenterology

 Takeda Pharmaceutical Company Limited ("Takeda") today held a briefing for investors and analysts in New York, discussing the company's...

Jan 12, 2015, 08:00 ET

Prasco and Takeda Enter into Agreement to Market Authorized Generic of Colcrys® (colchicine, USP) in the United States

CINCINNATI and DEERFIELD, Ill., Jan. 12, 2015 /PRNewswire/ -- Prasco Laboratories ("Prasco"), Takeda Pharmaceutical Company Limited...

Oct 27, 2014, 11:00 ET

Trate los síntomas del reflujo gracias a la Food4GERD App

La enfermedad del reflujo gastroesofágico (GERD), a menudo conocida como ardor de estómago, es un problema importante para muchas...

Oct 20, 2014, 08:00 ET

Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets for Chronic Weight Management in Obese Adults

 Takeda Pharmaceutical Company Limited ("Takeda"), its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A., Inc. and Orexigen®...

Aug 28, 2014, 12:09 ET

Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS

Takeda Pharmaceutical Company Limited ("Takeda") today announced the completion of the post-marketing commitment and submissions of data from...

Jul 10, 2014, 09:00 ET

Takeda and Zinfandel Pharmaceuticals to Present Data at Upcoming Alzheimer's Association International Conference® Highlighting Innovative Approaches to Alzheimer's Disease Research and Development

 Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc. ("Zinfandel"), will present data during...

Jun 17, 2014, 09:00 ET

Results of a New Study of Brintellix® (vortioxetine) vs. Escitalopram on Sexual Functioning in Well Treated MDD Patients Experiencing Treatment-Emergent Sexual Dysfunction

Takeda Pharmaceuticals Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will present results about sexual...

Jun 16, 2014, 10:00 ET

ENTYVIO™ (vedolizumab) Now Available in the United States for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis and Crohn's Disease

 Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced the...

Jun 16, 2014, 06:30 ET

New CONNECT Study Presents data on Measures of Cognitive Performance in Adult Patients Treated with Brintellix® (vortioxetine) for Major Depressive Disorder

 Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced results from CONNECT, a new study that evaluated...

May 20, 2014, 18:14 ET

FDA Approves Takeda's Entyvio™ (vedolizumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the...

Mar 27, 2014, 08:00 ET

Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

Takeda Pharmaceutical Company Limited (Takeda) will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes:...

Dec 24, 2013, 10:57 ET

Takeda Announces Extension of FDA PDUFA Action Date for Vedolizumab for Ulcerative Colitis

 Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that...

Dec 09, 2013, 20:09 ET

FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab

 Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that a...

Sep 30, 2013, 23:15 ET

Takeda and Lundbeck Announce FDA Approval of Brintellix™ (vortioxetine) for Treatment of Adults with Major Depressive Disorder

 Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) jointly announced today that the U.S. Food and Drug...

Sep 20, 2013, 09:00 ET

Takeda Cares Day Raises $63,700

 Takeda, a top 15 global pharmaceutical company, will raise money for local organizations today when employees participate in their third...

Sep 17, 2013, 14:38 ET

Takeda's Deerfield Campus Ranked Among 2013 Working Mother 100 Best Companies

Takeda Pharmaceuticals today announced Working Mother has listed Takeda among the top 100 companies for working mothers. Takeda's Deerfield campus...